State of Alaska Department of Revenue decreased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 5.5% in the 4th quarter, Holdings Channel.com reports. The fund owned 13,731 shares of the company’s stock after selling 795 shares during the period. State of Alaska Department of Revenue’s holdings in Neurocrine Biosciences were worth $1,169,000 […]
Wall Street analysts expect that Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) will report sales of $297.75 million for the current fiscal quarter, Zacks reports. Eleven analysts have issued estimates for Neurocrine Biosciences’ earnings, with the lowest sales estimate coming in at $235.50 million and the highest estimate coming in at $323.00 million. Neurocrine Biosciences […]
First Hawaiian Bank acquired a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 8,793 shares of the company’s stock, valued at approximately $749,000. Other large investors also recently modified their holdings […]